Alur Klinis dan Biaya Pengobatan Rumatan Metadon di Rumah Sakit Ketergantungan Obat Jakarta

Ronnie Rivany

Abstract


Dampak penyalahgunaan narkoba antara lain adalah peningkatan prevalensi HIV/AIDS di kalangan pengguna narkoba suntik. Program Terapi Rumatan Metadon merupakan salah satu cara penanganan yang kini belummempunyai alur klinis yang berfungsi menjamin standar kualitas pelayanan. Di samping itu, belum ada ketentuan yang dapat dijadikan acuan biaya pengobatan. Tujuan penelitian ini adalah membuat alur klinis dan biaya pengobatan rumatan metadon dan casemix di Rumah Sakit Ketergantungan Obat (RSKO) Jakarta. Metode penelitian merujuk INADRG yang berbasis evidence dengan diskusi kelompok, tenaga medis dan tenaga non medis serta profesi dan manajemen RSKO. Berdasarkan jumlah dan jenis utilisasi dalam alur klinis maka biaya pengobatan dilakukan dengan metode activity based costing dan simple distribution methode. Alur klinis yang diperoleh menunjukkan lama rumatan metadon 338 hari dengan casemix TBC, Hepatitis dan HIV/AIDS atau kombinasi. Biaya pengobatan rumatan metadon Rp.66.024.016, dengan casemix penyakit penyulit berkisar antara Rp. 70.156.705 hingga Rp.211.863.018 dan Rp. 84.875.621 hingga Rp. 226.988.354. dengan kombinasi penyakit penyulit dan penyerta. Kata kunci: INA-DRG’s, sistem pembayaran berbasis diagnosis, alur klinis, biaya pengobatanAbstractThe drug abuse implicated in increasing HIV/AIDS prevalence among injection drug users. As an alternative treatment, Methadone Maintenance Treatment (MMT) have not yet equipped with clinical pathway that function as a tool for assuring the standard quality of services. Beside that, treatment cost as average standard cost of health care services. The purpose of this study were to design and apply clinical pathway and treatment cost of MMT along with its casemix in Drugs Dependence Hospital Jakarta (DDHJ).Method used were INA-DRG based on evidence from medical record and focus group discussion involving medical and non-medical staff, related professional organization and hospital management. Based on numbers and types of treatment utilizated in clinical pathway, treatment cost was calculatedby using activity based costing with simple distribution method. This study found that the length of stay for MMTP was 338 days, casemix consisted of TB, Hepatitis, HIV/AIDS and its combination. Treatment cost for MMTP was IDR 66.024.016, casemix for complicating disease ranging fromIDR 70.156.705 to IDR 211.863.018, and IDR 84.875.621 to IDR 226.988.354 for casemix combination of complicating and comorbidity diseases.Key words: INA-DRG’s, diagnosis related groups, clinical pathway, medical expenses

Full Text:

PDF


DOI: http://dx.doi.org/10.21109/kesmas.v5i2.154

Refbacks

  • There are currently no refbacks.